Thalidomide as an Adjunctive Therapy for HIV-Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome: A Case Series. [PDF]
Lee-Jones S +5 more
europepmc +1 more source
Correction: Batsaikhan et al. Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6'-Dithiothalidomide on Traumatic Brain Injury. <i>Int. J. Mol. Sci.</i> 2019, <i>20</i>, 502. [PDF]
Batsaikhan B +8 more
europepmc +1 more source
Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial. [PDF]
Yang S +9 more
europepmc +1 more source
Integrated computational screen and validation of thalidomide-based PROTACs targeting SARS-CoV-2 main protease. [PDF]
Guo LN +5 more
europepmc +1 more source
Genetic modifiers of response to thalidomide in transfusion-dependent beta-thalassemia patients: a whole-exome sequence analysis. [PDF]
Bawazir WM +9 more
europepmc +1 more source
Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
J. Bray +3 more
semanticscholar +1 more source
Burden of Treatment, Treatment Sequencing and Healthcare Resource Utilization in Multiple Myeloma in Latin America: A Targeted Literature Review. [PDF]
Seehaus CM +9 more
europepmc +1 more source
Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry. [PDF]
Babu EM +8 more
europepmc +1 more source

